Public Sector Pension Investment Board Exelixis, Inc. Transaction History

Public Sector Pension Investment Board

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$18.93 - $24.75 $2.27 Million - $2.97 Million	-120,000 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$19.6 - $24.76 $2.35 Million - $2.97 Million	120,000 New	120,000 $2.86 Million
Q4 2018 Feb 14, 2019	SELL	$13.65 - $21.8 $1.07 Million - $1.7 Million	-78,100 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$15.87 - $22.4 $1.24 Million - $1.75 Million	78,100 New	78,100 $1.38 Million
Q1 2018 May 10, 2018	SELL	$22.15 - $31.89 $1.86 Million - $2.68 Million	-83,900 Closed	0 $0
Q4 2017 Feb 02, 2018	BUY	$24.23 - $30.93 $2.03 Million - $2.6 Million	83,900	83,900 $2.55 Million

503

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

Stay updated on Public Sector Pension Investment Board with notifications on news.